Huakang Biomedical Holdings Company Limited (8622.HK)
- Previous Close
0.101 - Open
0.100 - Bid 0.099 x --
- Ask 0.104 x --
- Day's Range
0.097 - 0.102 - 52 Week Range
0.091 - 0.222 - Volume
216,000 - Avg. Volume
1,699,866 - Market Cap (intraday)
51.048M - Beta (5Y Monthly) -0.09
- PE Ratio (TTM)
-- - EPS (TTM)
-0.020 - Earnings Date Mar 28, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China, Hong Kong, and Canada. The company provides male fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; and auxiliary reproductive supplies and equipment. It also offers healthcare products and supplements under the Nutronic brand through its websites, including nutronic.ca and nutronic.hk; offline channels, such as Eugenebaby and green price shops; and e-commerce platforms comprising Tmall, JD.com, Amazon, HKTVmall, Eugenebaby, etc. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is based in Tsim Sha Tsui, Hong Kong.
www.huakangbiomedical.com96
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 8622.HK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 8622.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 8622.HK
Valuation Measures
Market Cap
51.05M
Enterprise Value
17.93M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.59
Price/Book (mrq)
0.93
Enterprise Value/Revenue
0.73
Enterprise Value/EBITDA
-3.13
Financial Highlights
Profitability and Income Statement
Profit Margin
-23.48%
Return on Assets (ttm)
-6.37%
Return on Equity (ttm)
-10.75%
Revenue (ttm)
24.63M
Net Income Avi to Common (ttm)
-5.78M
Diluted EPS (ttm)
-0.020
Balance Sheet and Cash Flow
Total Cash (mrq)
32.94M
Total Debt/Equity (mrq)
10.07%
Levered Free Cash Flow (ttm)
--
Company Insights: 8622.HK
8622.HK does not have Company Insights